Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Derma Sciences (DSCI) Stock Price
News headlines about Derma Sciences (NASDAQ:DSCI) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Derma Sciences earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned news stories about the medical instruments supplier an impact score of 44.674786954103 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
About Derma Sciences
Derma Sciences, Inc (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection.
Receive News & Ratings for Derma Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Derma Sciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.